Pelthos Therapeutics Inc. (PTHS)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $28.10M
Last updated: Nov 17, 2026 at 4:10 PM ET
Pelthos Therapeutics Inc. (PTHS) Stock Chart
Pelthos Therapeutics (PTHS) has a latest price of $6.89 on Nov 17, 2026. Its price fell 79.5% over the past 12 months.
Price Chart
From Feb 2024 to Oct 2026, its highest month-end close was $37.70 in Feb 2024 and its lowest $6.11 in Nov 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PTHS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PTHS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 73.3%, and over 6 months it fell 74.5%.
| Period | Change |
|---|---|
| 1 month | -66.0% |
| 3 months | -73.3% |
| 6 months | -74.5% |
| 12 months | -79.5% |
| 12 months, with dividends | -79.5% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.40 | -69.7% |
| 2025 | $31.00 | +383.6% |
Trading Range
The price is 60.5% below its 50-day average of $17.46 and 70.4% below its 200-day average of $23.26.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.89 | |
| 50-day average | $17.46 | -60.5% |
| 200-day average | $23.26 | -70.4% |
Price Risk
Over 3 years, its largest fall from a peak was 88.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.01 |
| Largest fall, 1 year | -79.3% |
| Largest fall, 3 years | -88.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PTHS
What is PTHS's 1-year price change?
Pelthos Therapeutics's price fell 79.5% over the past 12 months. With dividends included, the 12-month total return was -79.5%.
What is PTHS's beta?
Pelthos Therapeutics's 1-year beta against the S&P 500 is 1.01, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 79.3%.
Is the PTHS chart free?
Yes. Advanced Charting for PTHS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PTHS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors